| Artículo | 2024 | C-terminal deletion of RelA protein is suggested as a possible cause of infective endocarditis recurrence with Enterococcus faecium | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2023 | Antimicrobial activity of cefiderocol against the carbapenemase-producing enterobacter cloacae complex and characterization of reduced susceptibility associated with metallo-b-lactamase VIM-1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2023 | Safety of early oral ambulatory treatment of adult patients with bloodstream infections discharged from the emergency department. | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2023 | Synergistic effect of SOS response and GATC methylome suppression on antibiotic stress survival in Escherichia coli | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2022 | Characterization of Extended-Spectrum beta-Lactamase-Producing Shigella sonnei in Spain: Expanding the Geographic Distribution of Sequence Type 152/CTX-M-27 Clone | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2022 | Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2022 | Early use of Sarilumab in patients hospitalised with COVID-19 pneumonia and features of systemic inflammation. | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2022 | In vitro activity of cefepime-taniborbactam against carbapenemase-producing enterobacterales and pseudomonas aeruginosa isolates recovered in Spain | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Activity of fosfomycin and amikacin against fosfomycin-heteroresistant Escherichia coli strains in a hollow-fiber infection model | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Amikacin combined with fosfomycin for treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: results from a Spanish multicenter cohort | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Corrección | 2021 | Erratum for Herrera-Hidalgo et al., "Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs?" | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Corrección | 2021 | Erratum: Ampicillin and ceftriaxone solution stability at different temperatures in outpatient parenteral antimicrobial therapy (Antimicrobial Agents and Chemotherapy (2020) 64:7 (e00309-20) DOI: 10.1128/AAC.00309-20) | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Interplay among different fosfomycin resistance mechanisms in klebsiella pneumoniae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs? | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2021 | Synergistic quinolone sensitization by targeting the recA SOS response gene and oxidative stress | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 | A randomized, double-blind, placebo-controlled trial (TAURCAT Study) of citrate lock solution for prevention of endoluminal central venous catheter infection in neutropenic hematological patients | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 | Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and lsogenic beta-Lactam-Resistant Mutants | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 | Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 | Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to pseudomonas aeruginosa | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 | Impact of KPC production and high-level meropenem resistance on all-cause mortality of ventilator-associated pneumonia in association with klebsiella pneumoniae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 | Modulation of monocyte activation and function during direct antiviral agents treatment in HIV coinfected patients | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2020 | Unexpected Cell Wall Alteration-Mediated Bactericidal Activity of the Antifungal Caspofungin against Vancomycin-Resistant Enterococcus faecium | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2019 | Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In Vivo | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2019 | OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014-2015 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2019 | Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 2018 | Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2018 | Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study) | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2018 | Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2018 | Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2018 | Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2017 | Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Corrección | 2017 | Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis" | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2017 | Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2017 | Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2017 | Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological Conditions | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2017 | Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | A Multinational, Preregistered Cohort Study of beta-Lactam/beta-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant beta-Lactam Resistance Mechanisms | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Revisión | 2016 | Optimizing the Clinical Use of Vancomycin | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2016 | Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2015 | Effects of a mutation in the gyrA gene on the virulence of uropathogenic Escherichia coli | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2015 | Mobile Genetic Elements Related to the Diffusion of Plasmid-Mediated AmpC beta-Lactamases or Carbapenemases from Enterobacteriaceae: Findings from a Multicenter Study in Spain | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2015 | Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2015 | Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals High In Vitro Susceptibility to Colistin and Meropenem | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2015 | Telaprevir and Ribavirin Interaction: Higher Ribavirin Levels Are Not Only Due to Renal Dysfunction during Triple Therapy | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Editorial | 2015 | The Times They Are a-Changin': Carbapenems for Extended-Spectrum-beta-Lactamase-Producing Bacteria | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2014 | Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2014 | Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical Isolates | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2014 | Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in spain in 2010 and 2011 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2014 | Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2014 | Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2014 | Population Pharmacokinetics of Teicoplanin in Children | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2014 | Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Contribution of Efflux Pumps, Porins, and beta-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Cost-Effectiveness Analysis Comparing Two Approaches for Empirical Antifungal Therapy in Hematological Patients with Persistent Febrile Neutropenia | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | First Report of an OXA-23 Carbapenemase-Producing Acinetobacter baumannii Clinical Isolate Related to Tn2006 in Spain | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Fosfomycin-Daptomycin and Other Fosfomycin Combinations as Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-beta-Lactamase-Producing Escherichia coli | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Inoculum Effect on the Efficacies of Amoxicillin-Clavulanate, Piperacillin-Tazobactam, and Imipenem against Extended-Spectrum beta-Lactamase (ESBL)-Producing and Non-ESBL-Producing Escherichia coli in an Experimental Murine Sepsis Model | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Lopinavir Plasma Concentrations and Virological Outcome with Lopinavir-Ritonavir Monotherapy in HIV-1-Infected Patients | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 2013 | Loss of the OprD Homologue Protein in Acinetobacter baumannii: Impact on Carbapenem Susceptibility | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2013 | OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Correlation of the Virological Response to Short-Term Maraviroc Monotherapy with Standard and Deep-Sequencing-Based Genotypic Tropism Prediction Methods | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Effect of Maraviroc on HIV Disease Progression-Related Biomarkers | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Efficacy of Daptomycin versus Vancomycin in an Experimental Model of Foreign-Body and Systemic Infection Caused by Biofilm Producers and Methicillin-Resistant Staphylococcus epidermidis | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Expression of OXA-type and SFO-1 β-lactamases induces changes in peptidoglycan composition and affects bacterial fitness | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Genomewide Overexpression Screen for Fosfomycin Resistance in Escherichia coli: MurA Confers Clinical Resistance at Low Fitness Cost | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | HIV-1 Tropism Evolution after Short-Term Maraviroc Monotherapy in HIV-1-Infected Patients | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based Analysis | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream Infections | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2012 | Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2011 | Analysis of Genes Encoding Penicillin-Binding Proteins in Clinical Isolates of Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2011 | First Face Composite-Tissue Transplant Recipient Successfully Treated for Cytomegalovirus Infection with Preemptive Valganciclovir Treatment | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2011 | In Vitro Effect of qnrA1, qnrB1, and qnrS1 Genes on Fluoroquinolone Activity against Isogenic Escherichia coli Isolates with Mutations in gyrA and parC | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2011 | Virological Response after Short-Term CCR5 Antagonist Exposure in HIV-Infected Patients: Frequency of Subjects with Virological Response and Associated Factors | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | Antimicrobial Resistance among Respiratory Pathogens in Spain: Latest Data and Changes over 11 Years (1996-1997 to 2006-2007) | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | Characterization of DIM-1, an Integron-Encoded Metallo-beta-Lactamase from a Pseudomonas stutzeri Clinical Isolate in the Netherlands | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | Extended-Spectrum Cephalosporinase in Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | Genetic and functional variability of AmpC-type â-lactamases from Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | Risk Factors for Fluconazole-Resistant Candidemia | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2010 | VIM-19, a Metallo-beta-Lactamase with Increased Carbapenemase Activity from Escherichia coli and Klebsiella pneumoniae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2009 | Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2009 | Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2009 | Genetic Variability among ampC Genes from Acinetobacter Genomic Species 3 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 2009 | In Vitro Activities of Tigecycline, Minocycline, and Colistin-Tigecycline Combination against Multi- and Pandrug-Resistant Clinical Isolates of Acinetobacter baumannii Group | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2009 | In Vitro Activity and In Vivo Efficacy of Clavulanic Acid against Acinetobacter baumannii | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2009 | Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2009 | Naturally Occurring Class A beta-Lactamases from the Burkholderia cepacia Complex | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2009 | Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic Impairment | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2008 | Characterization of the carbapenem-hydrolyzing oxacillinase Oxa-58 in an Acinetobacter genospecies 3 clinical isolate | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 2008 | Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Editorial | 2008 | qnr gene nomenclature | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2007 | Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2007 | Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2007 | Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2006 | Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: Molecular basis for the differential mechanisms of action | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2006 | Common region CR1 for expression of antibiotic resistance genes | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2006 | Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: Comparison with CLSI broth microdilution method | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2006 | In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Comparison of susceptibility testing procedures | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2006 | In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2006 | Intracellular penetration and activity of DX-619 in human polymorphonuclear leukocytes | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2005 | Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-lactamase | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2005 | Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2005 | Origin of plasmid-mediated quinolone resistance determinant QNRA | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2005 | Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: Correlation with results of NCCLS M27-A2 multicenter study | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2004 | Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2004 | Antimicrobial susceptibility and mechanisms of resistance to quinolones and beta-lactams in Acinetobacter genospecies 3 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 2004 | Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2003 | Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2003 | Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2003 | Zinc eluted from siliconized latex urinary catheters decreases OprD expression, causing carbapenem resistance in Pseudomonas aeruginosa | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2002 | Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2002 | Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2001 | Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2000 | Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2000 | Correlation of fluconazole MICs with clinical outcome in Cryptococcal infection | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2000 | Intracellular penetration and activity of gemifloxacin in human polymorphonuclear leukocytes | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 2000 | Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1999 | Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1999 | Resistance of Pseudomonas aeruginosa to imipenem induced by eluates from siliconized latex urinary catheters is related to outer membrane protein alterations | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1999 | Roles of beta-lactamases and porins is activities of carbapenems and cephalosporins against Klebsiella pneumoniae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1999 | Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1998 | Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Corrección | 1998 | Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains (vol 42, pg 1850, 1998) | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1998 | In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteria | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 1997 | Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1997 | Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1996 | Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1996 | Antimicrobial susceptibility pattern of Corynebacterium striatum | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Letter | 1996 | Cefuroxime efficacy in treatment of bacteremic pneumonia due to penicillin-resistant and cefuroxime-resistant Streptococcus pneumoniae | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1995 | Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal-fluid of and cerebral extracellular-space in awake rats by in-vivo microdialysis | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1995 | DOXYCYCLINE-RIFAMPIN VERSUS DOXYCYCLINE-STREPTOMYCIN IN TREATMENT OF HUMAN BRUCELLOSIS DUE TO BRUCELLA-MELITENSIS | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Nota | 1994 | COMPARATIVE ACTIVITIES OF 8 QUINOLONES AGAINST MEMBERS OF THE BACTEROIDES-FRAGILIS GROUP | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1994 | INTRACELLULAR PENETRATION AND ACTIVITY OF BAY-Y-3118 IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1993 | UPTAKE AND INTRACELLULAR ACTIVITY OF FLUCONAZOLE IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1992 | UPTAKE AND INTRACELLULAR ACTIVITY OF SPARFLOXACIN IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES AND TISSUE-CULTURE CELLS | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1990 | MULTICENTER PROSPECTIVE-STUDY OF TREATMENT OF BRUCELLA-MELITENSIS BRUCELLOSIS WITH DOXYCYCLINE FOR 6 WEEKS PLUS STREPTOMYCIN FOR 2 WEEKS | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1990 | Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1989 | FLUOROMETRIC MEASUREMENT OF OFLOXACIN UPTAKE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Nota | 1986 | EFFECT OF MEDIUM, PH, AND INOCULUM SIZE ON ACTIVITY OF CEFTIZOXIME AND SCH-34343 AGAINST ANAEROBIC-BACTERIA | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1985 | ACTIVITIES OF NEW QUINOLINE DERIVATIVES AGAINST GENITAL PATHOGENS | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Artículo | 1980 | COMPARATIVE INVITRO ACTIVITY OF 1-OXA-BETA-LACTAM (LY127935) AND CEFOPERAZONE WITH OTHER BETA-LACTAM ANTIBIOTICS AGAINST ANAEROBIC-BACTERIA | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
